COVID-19: Zydus Cadila Seeks DCGI Nod For Human Clinical Trials

New Delhi, May 27 (PTI) Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India (DCGI) to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19. "Zydus is currently seeking permission to initiate

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3bYazPR